Year in Review: Top Deals in 2023
Acuitas Files Suit Against CureVac Alleging Incorrect Inventorship on COVID MRNA-LNP Vaccine Patent Family
Amneal Expands Oncology Offering with Two Denosumab Biosimilars
Acuitas Seeks Declaratory Judgment of Non-Infringement and Invalidity Against Arbutus and Genevant in New Jersey Court Challenging mRNA-Delivery Specific Patents
Biocon Completes Integration of Viatris Biosimilars Business
Regeneron Received FDA Complete Response Letter For Its Higher Dose Aflibercept Injection BLA
Alnylam Files New COVID-19 Vaccine Infringement Lawsuits Against Pfizer and Moderna
Insulin Updates: March 2023
PTAB Institutes Mylan’s Two EYLEA (aflibercept) IPRs
Subscribe: Subscribe via RSS
Blogs
Firm/Org